Benefits of the Use of Botox in the Treatment of Empty Nose Syndrome Syndrome
| Status: | Terminated |
|---|---|
| Conditions: | Allergy |
| Therapuetic Areas: | Otolaryngology |
| Healthy: | No |
| Age Range: | 18 - 65 |
| Updated: | 4/21/2016 |
| Start Date: | December 2008 |
| End Date: | November 2009 |
Prospective Case Series Evaluating Short and Long Term Benefits of the Use of Botox in the Treatment of Empty Nose Syndrome
Empty Nose Syndrome patients suffer from disabling physical symptoms and considerable
distress. To date there is no definitive cure for these symptoms. Established treatment
modalities include saline irrigation, surgical implantation of materials or simply use of
cotton wads/ silicon cones to simulate the resistive action to airflow of the resected
turbinates.
This study will research the effectiveness of a new treatment modality in the treatment of
Empty Nose Syndrome. This novel treatment method involves the use of botulinum toxin type A
(Botox).
distress. To date there is no definitive cure for these symptoms. Established treatment
modalities include saline irrigation, surgical implantation of materials or simply use of
cotton wads/ silicon cones to simulate the resistive action to airflow of the resected
turbinates.
This study will research the effectiveness of a new treatment modality in the treatment of
Empty Nose Syndrome. This novel treatment method involves the use of botulinum toxin type A
(Botox).
Background:
Empty Nose Syndrome (ENS) is the term used to describe the condition resulting from over
resection of nasal turbinate. Symptoms include depression, dysosmia, bleeding, discharge,
crusting, dryness, dysosmia, and pain.
Treatment modalities include adjunctive comfort measures (primarily irrigation), mechanical
measures (Silicon cones, cotton wads) and surgical treatment (alloderm implants, plastipore
cartilage grafts etc.) We will investigate a new method of treatment for ENS. This will
involve injection of botulinum toxin type A into the dilator nasalis muscle thus collapsing
the internal nasal valve to provide added resistance to air flow.
Objective:
To evaluate effectiveness of botulinum toxin type A in improving overall quality of life in
ENS patients.
Methods:
ENS patients in this study will receive botulinum toxin type A along with adjunctive
treatment which will include several measures. First of all, patients will be given a nasal
rinse bottle and will be instructed to irrigate their noses twice a day as follows:
- Irrigate the nose 250cc (about 125cc each side) to clear the mucus.
- Stop and gently clear the nose.
- Irrigate the nose 250cc (about 125cc each side) once again.
- Sit quietly for 10 minutes. No blowing.
- Do not blow the nose for 2 hours.
Patients will be asked to use sesame oil once a day to prevent drying of the nasal mucosa
with further administration as needed. In addition they will advised to make certain
lifestyle modifications that will include sleeping with a cool mist humidifier, drinking
plenty of fluids and engaging in regular physical activity.
Before and after treatment data will be obtained in the form of a breathing test and patient
questionnaires that will measure changes in physical and mental health.
Empty Nose Syndrome (ENS) is the term used to describe the condition resulting from over
resection of nasal turbinate. Symptoms include depression, dysosmia, bleeding, discharge,
crusting, dryness, dysosmia, and pain.
Treatment modalities include adjunctive comfort measures (primarily irrigation), mechanical
measures (Silicon cones, cotton wads) and surgical treatment (alloderm implants, plastipore
cartilage grafts etc.) We will investigate a new method of treatment for ENS. This will
involve injection of botulinum toxin type A into the dilator nasalis muscle thus collapsing
the internal nasal valve to provide added resistance to air flow.
Objective:
To evaluate effectiveness of botulinum toxin type A in improving overall quality of life in
ENS patients.
Methods:
ENS patients in this study will receive botulinum toxin type A along with adjunctive
treatment which will include several measures. First of all, patients will be given a nasal
rinse bottle and will be instructed to irrigate their noses twice a day as follows:
- Irrigate the nose 250cc (about 125cc each side) to clear the mucus.
- Stop and gently clear the nose.
- Irrigate the nose 250cc (about 125cc each side) once again.
- Sit quietly for 10 minutes. No blowing.
- Do not blow the nose for 2 hours.
Patients will be asked to use sesame oil once a day to prevent drying of the nasal mucosa
with further administration as needed. In addition they will advised to make certain
lifestyle modifications that will include sleeping with a cool mist humidifier, drinking
plenty of fluids and engaging in regular physical activity.
Before and after treatment data will be obtained in the form of a breathing test and patient
questionnaires that will measure changes in physical and mental health.
Inclusion Criteria:
- Any patient aged 18-65 years of age presenting with a known diagnosis of ENS who has
no known allergies to Botox.
Exclusion Criteria:
- Patients younger than 18 years or older than 65 years of age.
- Patients with neuromuscular disorders or neuropathic diseases.
- Patients with infection and or swelling at the site where Botox is to be injected.
- Patients with known hypersensitivity to any ingredient in the drug formulation
(botulinum toxin, human albumin)
- Patients who are or plan to become pregnant within the time period in which the study
will be conducted.
- Patients who are nursing
We found this trial at
1
site
Click here to add this to my saved trials
